OXiGENE, Inc. (NASDAQ:OXGN) shares moved down -4.09% in last trading session and ended the day at $0.79. OXGN has a return on assets of -37.50%. OXiGENE, Inc. (NASDAQ:OXGN) quarterly performance is 6.59%.
OXiGENE, Inc. (NASDAQ:OXGN) announced that Simon C. Pedder, Ph.D. has been appointed to OXiGENE’s board of directors, effective March 21, 2016.
Annaly Capital Management, Inc. (NYSE:NLY) caters to the Financial space. It has a net profit margin of 34.10% and weekly performance is 1.39%. On the last day of trading company shares ended up at $10.26. Annaly Capital Management, Inc. (NYSE:NLY) distance from 50-day simple moving average (SMA50) is 6.67%.
Annaly Capital Management, Inc. (NYSE:NLY) has declared a Series A Preferred Stock cash dividend for the first quarter 2016 of $0.492188 per share of Series A Preferred Stock. This dividend is payable on March 31, 2016, to Series A Preferred Stock shareholders of record as of March 1, 2016.
Goldcorp Inc. (NYSE:GG) ended the last trading day at $16.23. Company weekly volatility is calculated as 3.99% and price to cash ratio as 35.21. Goldcorp Inc. (NYSE:GG) showed a weekly performance of 5.32%.
Goldcorp Inc. (NYSE:GG) announced that it has reduced its annual dividend to $0.08 per share effective April 1, 2016 and amended its dividend payment schedule such that future dividends will be paid quarterly commencing in June 2016.
Cogentix Medical, Inc. (NASDAQ:CGNT) shares advanced 4.76% in last trading session and ended the day at $1.10. CGNT Gross Margin is 74.90% and its has a return on assets of -35.80%. Cogentix Medical, Inc. (NASDAQ:CGNT) quarterly performance is -14.06%.
Cogentix Medical Inc (NASDAQ:CGNT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Friday,Marketbeat.com reports. The firm presently has a $1.25 price target on the medical device company’s stock. Zacks Investment Research‘s price objective suggests a potential upside of 12.61% from the stock’s previous close.
NeuroMetrix Inc. (NASDAQ:NURO) caters to the Healthcare space. Its weekly performance is 10.91%. On the last day of trading company shares ended up at $1.83. NeuroMetrix Inc. (NASDAQ:NURO) distance from 50-day simple moving average (SMA50) is 6.18%.
NeuroMetrix Inc. (NASDAQ:NURO) announced that Premera Blue Cross, a leading health plan in the Pacific Northwest, will pilot the Quell Wearable Pain Relief device within their organization. Through this innovative collaboration, Premera will provide Quell devices to selected employees with chronic pain. The pilot will assess employees’ response to the technology and its impact on their pain and quality of life. The pilot will also analyze numerous objective data points including device utilization and sleep metrics that are automatically captured via Quell’s smartphone app.